{
  "type": "team",
  "agenda": "Synthesize all expert recommendations into integrated, implementable APOE analysis pipeline with realistic prioritization for ~300 candidate genes (Parallel Session 2)",
  "participants": [
    "Dr. Sarah Chen",
    "Dr. Raj Patel",
    "Dr. Lisa Wang",
    "Dr. Michael Torres",
    "Dr. Elena Rodriguez",
    "Dr. Alex Cho"
  ],
  "rounds": 3,
  "response": "VIRTUAL LAB TEAM MEETING: APOE Analysis Pipeline Development\n\n**ROUND 1: Initial Recommendations**\n\nDr. Sarah Chen (LD Reference Panel):\n- Primary recommendation: Use population-matched 1000G reference panels with careful stratification\n- Minimum 3 reference populations (EUR, EAS, AFR) for cross-population validation\n- Generate local LD matrices using 5Mb window around APOE region\n- Implement sliding window approach for LD calculation to capture long-range effects\n- Quality metrics: R\u00b2 threshold >0.8, minimum MAF >1% for reliable LD estimation\n\nDr. Raj Patel (Colocalization):\n- Deploy COLOC-SuSiE for handling multiple causal variants\n- Parallel implementation of eCAVIAR for cross-validation\n- Prior probability parameters: p1=1e-4, p2=1e-4, p12=1e-5\n- Colocalization threshold PP4>0.8 with sensitivity analysis\n- Generate regional colocalization plots for visual inspection\n\nDr. Lisa Wang (Fine-mapping):\n- Primary: SuSiE with adaptive L parameter selection\n- Secondary: FINEMAP for cross-validation\n- PolyFun integration for functional priors\n- Credible set threshold 95% coverage\n- Independent signal threshold: r\u00b2 < 0.1\n\nDr. Michael Torres (APOE Biology):\n- Prioritize known regulatory elements: enhancers, promoters\n- Focus on APOE-pathway genes (TOMM40, APOC1, CLU)\n- Stratify analysis by E2/E3/E4 background\n- Include chromatin interaction data from brain tissue\n- Consider tissue-specific eQTL effects\n\nDr. Elena Rodriguez (Scientific Critique):\n- Implement systematic bias checks\n- Population stratification sensitivity analysis\n- Power calculations for effect size detection\n- Multiple testing correction framework\n- Reproducibility metrics definition\n\nDr. Alex Cho (Implementation):\n- Snakemake workflow for pipeline automation\n- Containerized environment (Docker/Singularity)\n- GPU acceleration for computation-intensive steps\n- Automated QC report generation\n- Version control and documentation\n\n**ROUND 2: Integration and Refinement**\n\nCross-cutting Recommendations:\n\n1. LD Analysis Integration:\n- Dr. Chen + Dr. Wang: Integrate LD reference selection with fine-mapping\n- Population-specific LD matrices for each analysis step\n- Joint QC metrics for LD calculation and fine-mapping\n\n2. Molecular QTL Analysis:\n- Dr. Patel + Dr. Torres: Tissue-specific colocalization\n- Brain-specific eQTL prioritization\n- Integration with chromatin interaction data\n\n3. Statistical Framework:\n- Dr. Rodriguez + Dr. Wang: Joint statistical framework\n- FDR control across multiple analyses\n- Power analysis for prioritization\n\n4. Implementation Strategy:\n- Dr. Cho + All: Modular pipeline development\n- Automated validation checks\n- Reproducibility framework\n\n**ROUND 3: Synthesis and Implementation**\n\nFinal Pipeline Structure:\n\n1. Data Preprocessing (Week 1-2):\n- QC of GWAS and molecular QTL data\n- LD reference panel preparation\n- Population stratification analysis\n\n2. Primary Analysis (Week 3-4):\n- Fine-mapping with SuSiE\n- Colocalization analysis\n- Regulatory element annotation\n\n3. Validation Phase (Week 5-6):\n- Cross-population validation\n- Sensitivity analyses\n- QC metric evaluation\n\n4. Gene Prioritization Strategy:\nTier 1 (~50 genes):\n- Known APOE pathway genes\n- Strong regulatory evidence\n- High-confidence colocalization\n\nTier 2 (~100 genes):\n- Moderate statistical evidence\n- Tissue-specific effects\n- Secondary pathway connections\n\nTier 3 (~150 genes):\n- Remaining candidates\n- Exploratory analyses\n- Novel hypotheses\n\nAction Items and Assignments:\n\nDr. Chen:\n- Develop LD reference panel pipeline\n- Generate population-specific matrices\n- Timeline: Weeks 1-2\n\nDr. Patel:\n- Implement colocalization workflow\n- Develop visualization tools\n- Timeline: Weeks 2-4\n\nDr. Wang:\n- Set up fine-mapping pipeline\n- Integrate functional priors\n- Timeline: Weeks 2-4\n\nDr. Torres:\n- Annotate regulatory elements\n- Prioritize biological pathways\n- Timeline: Weeks 3-5\n\nDr. Rodriguez:\n- Develop validation framework\n- Implement QC metrics\n- Timeline: Weeks 4-6\n\nDr. Cho:\n- Create pipeline infrastructure\n- Automate workflows\n- Timeline: Weeks 1-6\n\nResource Requirements:\n- High-performance computing cluster\n- 500GB storage minimum\n- 64GB RAM per node\n- GPU acceleration for intensive calculations\n\nFinal Deliverables (Week 6):\n1. Automated analysis pipeline\n2. Comprehensive QC reports\n3. Prioritized gene list with evidence\n4. Publication-ready figures\n5. Technical documentation\n\nThis complete pipeline will provide a robust, reproducible framework for analyzing the APOE region while addressing the complex challenges of LD structure and multiple causal variants.",
  "timestamp": "2025-08-11T13:21:08.817031"
}